Repression of LINC00518 expression using an shLINC00518 plasmid, or Santacruzamate A, reduced the tumorigenic ability of WM451 and A375 cells, and increased their radiosensitivity in the subcutaneous sarcoma model (Fig. 8A). This evidence concerns the gene LINC00518 and sarcoma.